Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Therapeutic Advances in Hematology
|
October 23, 2023
Rilzabrutinib <i>versus</i> placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
David J Kuter, James B Bussel, Waleed Ghanima, et al.
The Oncologist
|
September 28, 2017
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)
Nicole M Kuderer, Marek S Poniewierski, Eva Culakova, et al.
JNCI Cancer Spectrum
|
July 31, 2019
Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort Study
Davendra P S Sohal, Nicole M Kuderer, Frances A Shepherd, et al.
British Journal of Haematology
|
December 18, 2012
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)
Jeffrey I Zwicker, Howard A Liebman, Kenneth A Bauer, et al.
JCI Insight
|
January 18, 2019
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer
Jeffrey I Zwicker, Benjamin L Schlechter, Jack D Stopa, et al.
Research and Practice in Thrombosis and Haemostasis
|
February 4, 2021
Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method
Adam Cuker, Jenny M Despotovic, Rachael F Grace, et al.
Thrombosis and Haemostasis
|
December 24, 2024
Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit
Dimpy Modi, Saifur R Chowdhury, Syed Mahamad, et al.
American Journal of Hematology
|
December 11, 2019
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
Adrian C Newland, Blanca Sánchez-González, László Rejtő, et al.
Blood
|
September 29, 2021
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
Eun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2019
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S Key, Alok A Khorana, Nicole M Kuderer, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Therapeutic Advances in Hematology
|
October 23, 2023
Rilzabrutinib <i>versus</i> placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
David J Kuter, James B Bussel, Waleed Ghanima, et al.
The Oncologist
|
September 28, 2017
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)
Nicole M Kuderer, Marek S Poniewierski, Eva Culakova, et al.
JNCI Cancer Spectrum
|
July 31, 2019
Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort Study
Davendra P S Sohal, Nicole M Kuderer, Frances A Shepherd, et al.
British Journal of Haematology
|
December 18, 2012
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)
Jeffrey I Zwicker, Howard A Liebman, Kenneth A Bauer, et al.
JCI Insight
|
January 18, 2019
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer
Jeffrey I Zwicker, Benjamin L Schlechter, Jack D Stopa, et al.
Research and Practice in Thrombosis and Haemostasis
|
February 4, 2021
Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method
Adam Cuker, Jenny M Despotovic, Rachael F Grace, et al.
Thrombosis and Haemostasis
|
December 24, 2024
Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit
Dimpy Modi, Saifur R Chowdhury, Syed Mahamad, et al.
American Journal of Hematology
|
December 11, 2019
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
Adrian C Newland, Blanca Sánchez-González, László Rejtő, et al.
Blood
|
September 29, 2021
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
Eun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2019
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S Key, Alok A Khorana, Nicole M Kuderer, et al.
Page
of 7